FUNCTION OF THE C-MYC ONCOGENE
FUNCTION OF THE C-MYC ONCOGENE
批准号:
2096464
负责人:
MICHAEL David COLE
金额:
$27.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1998-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mutations that disrupt the regulation or expression level of the c-myc
gene are frequently found in human and animal cancers. Ectopic expression
studies define numerous biological activities of the c-myc gene, including
transformation, immortalization, blockage of cell differentiation and
induction of apoptosis. Since the Myc proteins bind to specific DNA
sequences, the mechanisms of cell transformation can be viewed as that of
a transcription factor that activates specific target genes. Functional
studies have demonstrated that two specific domains of the c-Myc protein
are essential for cell transformation: the C-terminal 100 amino acids
which encompass the DNA binding region, and a small 20 amino acid segment
from the N-terminus (called Myc Box 2) that is conserved in all members of
the myc family of genes. Since the DNA binding region is well
characterized, the major functional domain of the c-Myc protein that
remains undefined is Myc Box 2.
This project will address the function of Myc Box 2 through an analysis of
the nuclear proteins that bind to this region and which are also essential
for the transforming activity of the oncogene. The experimental approach
is based on preliminary studies i which dominant interfering alleles of
the c-Myc protein were shown to form protein complexes that are dependent
on the integrity of Myc Box 2 and hence correlate with nuclear factors
that may be essential for c-Myc function. The specific aims are as
follows:
1. An essential, rate-limiting nuclear factor (termed MB2F) which binds
to the c-Myc amino terminus through Myc Box 2 will be purified
biochemically and the corresponding cDNA will be cloned.
2. The function of MB2F will be addressed through studies of potential
transforming activity and interactions with nuclear components.
3. The requirement of MB2F for transformation by other oncogenes will be
assessed. In particular, we will test if MB2F is essential for
transformation by another nuclear oncogene, the adenovirus E1a gene, and
a tyrosine kinase oncogene, BCR-abl.
4. The potential regulation of c-Myc protein interaction with the MB2F
cofactor by either extracellular stimuli or cell cycle progression will be
studied.
The long range goal of this project is to identify cellular promoters that
are dependent on both c-Myc and MB2F for their activation and hence
represent the downstream effectors of cell transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutic targeting of MYC interactions with an essential cofactor
-
批准号:10512309
-
项目类别:
-
资助金额:$23.0万
-
财政年份:2022
-
负责人:MICHAEL David COLE
-
依托单位:
Therapeutic targeting of MYC interactions with an essential cofactor
-
批准号:10655655
-
项目类别:
-
资助金额:$18.78万
-
财政年份:2022
-
负责人:MICHAEL David COLE
-
依托单位:
MYC Dependent Pathways in Apoptosis and Lymphomagenesis
-
批准号:7171755
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC Dependent Pathways in Apoptosis and Lymphomagenesis
-
批准号:7341057
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC Dependent Pathways in Apoptosis and Lymphomagenesis
-
批准号:7008498
-
项目类别:
-
资助金额:$35.13万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC DEPENDENT PATHWAYS IN APOPTOSIS AND LYMPHOMAGENESIS
-
批准号:6626634
-
项目类别:
-
资助金额:$31.2万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC DEPENDENT PATHWAYS IN APOPTOSIS AND LYMPHOMAGENESIS
-
批准号:6489192
-
项目类别:
-
资助金额:$30.48万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Myc Oncogene Mutations and Polymorphisms in Cancer
-
批准号:7995269
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC Dependent Pathways in Apoptosis and Lymphomagenesis
-
批准号:6733843
-
项目类别:
-
资助金额:$35.73万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Myc Oncogene Mutations and Polymorphisms in Cancer
-
批准号:7783140
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Myc Oncogene Mutations and Polymorphisms in Cancer
-
批准号:8196898
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC Dependent Pathways in Apoptosis and Lymphomagenesis
-
批准号:6850786
-
项目类别:
-
资助金额:$35.93万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC DEPENDENT PATHWAYS IN APOPTOSIS AND LYMPHOMAGENESIS
-
批准号:6137727
-
项目类别:
-
资助金额:$29.09万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC DEPENDENT PATHWAYS IN APOPTOSIS AND LYMPHOMAGENESIS
-
批准号:6342147
-
项目类别:
-
资助金额:$29.78万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Myc Oncogene Mutations and Polymorphisms in Cancer
-
批准号:8593230
-
项目类别:
-
资助金额:$32.67万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Myc Oncogene Mutations and Polymorphisms in Cancer
-
批准号:8383481
-
项目类别:
-
资助金额:$31.66万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
MYC DEPENDENT PATHWAYS IN APOPTOSIS AND LYMPHOMAGENESIS
-
批准号:2765954
-
项目类别:
-
资助金额:$28.66万
-
财政年份:1999
-
负责人:MICHAEL David COLE
-
依托单位:
Essential Effectors of Myc function
-
批准号:6688796
-
项目类别:
-
资助金额:$45.49万
-
财政年份:1992
-
负责人:MICHAEL David COLE
-
依托单位:
Essential Effectors of Myc function
-
批准号:6804537
-
项目类别:
-
资助金额:$46.85万
-
财政年份:1992
-
负责人:MICHAEL David COLE
-
依托单位:
Essential Effectors of Myc function
-
批准号:7247977
-
项目类别:
-
资助金额:$48.54万
-
财政年份:1992
-
负责人:MICHAEL David COLE
-
依托单位:
海外基金